Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in TBPH — Theravance Biopharma, Inc.

CIK 873630 LONDON, X0
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$840,276
+$139,076 QoQ
Shares Held
49,428
+14.4% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 179 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. TBPH ranks #55 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in TBPH

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $840,276 49,428
2026-03-31 $701,200 43,204
2025-12-31 $345,704 18,477
2025-09-30 $714,188 48,917
2025-06-30 $631,070 57,214
2024-06-30 $108,789 12,829
2021-03-31 $212,508 10,412
2020-12-31 $215,550 12,130
2020-09-30 $179,342 12,130
2020-06-30 $254,608 12,130
2020-03-31 $298,211 12,904